TY - JOUR
T1 - ERS/ESTS statement on the management of pleural infection in adults
AU - Bedawi, Eihab O.
AU - Ricciardi, Sara
AU - Hassan, Maged
AU - Gooseman, Michael R.
AU - Asciak, Rachelle
AU - Castro-Añón, Olalla
AU - Armbruster, Karin
AU - Bonifazi, Martina
AU - Poole, Sarah
AU - Harris, Elinor K.
AU - Elia, Stefano
AU - Krenke, Rafal
AU - Mariani, Alessandro
AU - Maskell, Nick A.
AU - Polverino, Eva
AU - Porcel, Jose M.
AU - Yarmus, Lonny
AU - Belcher, Elizabeth P.
AU - Opitz, Isabelle
AU - Rahman, Najib M.
N1 - Funding Information:
Support statement: This work was supported by the European Respiratory Society. Funding information for this article has been deposited with the Crossref Funder Registry.
Publisher Copyright:
Copyright © The authors 2023.
PY - 2023/2/1
Y1 - 2023/2/1
N2 - Pleural infection is a common condition encountered by respiratory physicians and thoracic surgeons alike. The European Respiratory Society (ERS) and European Society of Thoracic Surgeons (ESTS) established a multidisciplinary collaboration of clinicians with expertise in managing pleural infection with the aim of producing a comprehensive review of the scientific literature. Six areas of interest were identified: 1) epidemiology of pleural infection, 2) optimal antibiotic strategy, 3) diagnostic parameters for chest tube drainage, 4) status of intrapleural therapies, 5) role of surgery and 6) current place of outcome prediction in management. The literature revealed that recently updated epidemiological data continue to show an overall upwards trend in incidence, but there is an urgent need for a more comprehensive characterisation of the burden of pleural infection in specific populations such as immunocompromised hosts. There is a sparsity of regular analyses and documentation of microbiological patterns at a local level to inform geographical variation, and ongoing research efforts are needed to improve antibiotic stewardship. The evidence remains in favour of a small-bore chest tube optimally placed under image guidance as an appropriate initial intervention for most cases of pleural infection. With a growing body of data suggesting delays to treatment are key contributors to poor outcomes, this suggests that earlier consideration of combination intrapleural enzyme therapy (IET) with concurrent surgical consultation should remain a priority. Since publication of the MIST-2 study, there has been considerable data supporting safety and efficacy of IET, but further studies are needed to optimise dosing using individualised biomarkers of treatment failure. Pending further prospective evaluation, the MIST-2 regimen remains the most evidence based. Several studies have externally validated the RAPID score, but it requires incorporating into prospective intervention studies prior to adopting into clinical practice.
AB - Pleural infection is a common condition encountered by respiratory physicians and thoracic surgeons alike. The European Respiratory Society (ERS) and European Society of Thoracic Surgeons (ESTS) established a multidisciplinary collaboration of clinicians with expertise in managing pleural infection with the aim of producing a comprehensive review of the scientific literature. Six areas of interest were identified: 1) epidemiology of pleural infection, 2) optimal antibiotic strategy, 3) diagnostic parameters for chest tube drainage, 4) status of intrapleural therapies, 5) role of surgery and 6) current place of outcome prediction in management. The literature revealed that recently updated epidemiological data continue to show an overall upwards trend in incidence, but there is an urgent need for a more comprehensive characterisation of the burden of pleural infection in specific populations such as immunocompromised hosts. There is a sparsity of regular analyses and documentation of microbiological patterns at a local level to inform geographical variation, and ongoing research efforts are needed to improve antibiotic stewardship. The evidence remains in favour of a small-bore chest tube optimally placed under image guidance as an appropriate initial intervention for most cases of pleural infection. With a growing body of data suggesting delays to treatment are key contributors to poor outcomes, this suggests that earlier consideration of combination intrapleural enzyme therapy (IET) with concurrent surgical consultation should remain a priority. Since publication of the MIST-2 study, there has been considerable data supporting safety and efficacy of IET, but further studies are needed to optimise dosing using individualised biomarkers of treatment failure. Pending further prospective evaluation, the MIST-2 regimen remains the most evidence based. Several studies have externally validated the RAPID score, but it requires incorporating into prospective intervention studies prior to adopting into clinical practice.
UR - http://www.scopus.com/inward/record.url?scp=85142371848&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142371848&partnerID=8YFLogxK
U2 - 10.1183/13993003.01062-2022
DO - 10.1183/13993003.01062-2022
M3 - Article
C2 - 36229045
AN - SCOPUS:85142371848
SN - 0903-1936
VL - 61
JO - European Respiratory Journal, Supplement
JF - European Respiratory Journal, Supplement
IS - 2
M1 - 2201062
ER -